Analysis of Human to Human Transmission of Middle East Respiratory Syndrom Coronavirus (MER-CoV) (MKU)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02605109|
Recruitment Status : Completed
First Posted : November 16, 2015
Last Update Posted : September 1, 2016
|Condition or disease||Intervention/treatment|
|Viral Infection||Other: Risk of MERS infection|
Between May 2015 and Nov 2015, total 186 cases of MERS-Cov infections were reported in South Korea. In June 2015, a female patient visited our emergency department (ED) for care of femur fracture. She was suspected of having MERS-Cov and isolated after 10 hours from the visit of our hospital because her clinical feature was not concordance with typical MERS-Cov infection and she denied the any contact of MERS-Cov patient. Before the transport to the isolation room, she stayed at ED during 8 hours, and admitted the general ward during 2 hours. Approximately 150 including the healthcare providers, patients and laypersons were exposed to the case-patient directly or indirectly. The investigators monitored all possible contacts in the hospital during that time, and analysed the CCTV data of hospital and interviewed all risk-persons. After the hospital outbreak ended, The investigators analysed the data of all behavior and contact history of MERS patient, epidermic and clinical data of infected patients and data of personal protective equipments (PPE) of all exposed persons.
Descriptive analysis were conducted for basic epidemiology, transmission rout of MERS in hospital, and the effect of hospital infection control system and PPE of each contacts.
|Study Type :||Observational|
|Actual Enrollment :||200 participants|
|Official Title:||Analysis of Human to Human Transmission of Middle East Respiratory Syndrom Coronavirus (MER-CoV) and Infection Control Experiences in a Medical Institution of South Korea|
|Study Start Date :||June 2015|
|Actual Primary Completion Date :||November 2015|
|Actual Study Completion Date :||November 2015|
Exposed to case-patients
Other: Risk of MERS infection
HCPs, patients and layperson to closely or indirectly contact a case-patients
- Numbers of infected patient [ Time Frame: Serologic confimred MERS case within 4 weeks after contacting to a case patients ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02605109
|Study Director:||Hyun Kyun Ki, MD||Devision of Infection, Department of Medicine, School of Medicine, Konkuk University, Seoul 143-729, Korea|